Chemoinformaics analysis of 2,3,4-Trihydroxybenzoic acid
| Molecular Weight | 170.12 | nRot | 1 |
| Heavy Atom Molecular Weight | 164.072 | nRig | 17 |
| Exact Molecular Weight | 170.022 | nRing | 1 |
| Solubility: LogS | -3.378 | nHRing | 0 |
| Solubility: LogP | 5.956 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 19.7008 |
| nHD | 4 | BPOL | 6.88724 |
| QED | 0.487 |
| Synth | 3.777 |
| Natural Product Likeliness | 1.227 |
| NR-PPAR-gamma | 0.94 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.113 |
| HIA | 0.01 |
| CACO-2 | -5.301 |
| MDCK | 0.0000165 |
| BBB | 0.004 |
| PPB | 0.991396 |
| VDSS | 0.537 |
| FU | 0.0153781 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.685 |
| CYP2c19-inh | 0.266 |
| CYP2c19-sub | 0.098 |
| CYP2c9-inh | 0.772 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0.883 |
| CYP2d6-sub | 0.543 |
| CYP3a4-inh | 0.287 |
| CYP3a4-sub | 0.172 |
| CL | 5.047 |
| T12 | 0.744 |
| hERG | 0.165 |
| Ames | 0.099 |
| ROA | 0.306 |
| SkinSen | 0.963 |
| Carcinogencity | 0.28 |
| EI | 0.904 |
| Respiratory | 0.868 |
| NR-Aromatase | 0.059 |
| Antiviral | No |
| Prediction | 0.859715 |